Physician profile
Howard Lantner
NPI 1730127382
$150,641.62
in general payments reported to CMS, 2019-2025
8 companies · $1,748 in 2025
The $1,748 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48K · 2020: $38K · 2021: $32K · 2022: $25K · 2023: $4,236 · 2024: $1,248 · 2025: $1,748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $3,898 · Travel and Lodging: $2,403 · Food and Beverage: $931.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $3,897.51 |
| Travel and Lodging | $2,403.04 |
| Food and Beverage | $931.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $145,450.73 | 2019-2023 | Caliber |
| Stryker Corporation | $3,257.21 | 2020-2025 | Mako, Everest Spinal System, N/A |
| 4web, INC. | $1,000.00 | 2019 | |
| Depuy Synthes Sales INC. | $505.92 | 2019 | |
| Cerapedics INC. | $350.29 | 2023-2025 | I-Factor Peptide Enhanced Bone Graft |
| Zimvie INC. | $32.72 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $24.81 | 2024 | Exparel |
| Kowa Pharmaceuticals America, INC. | $19.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Lantner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.